Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate vs Flonase in Seasonal Allergic Rhinitis
NCT03882047Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 1994
- Primary completion
- Sep 1994
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR) (3 arms), sponsored by Organon & Co. Primary endpoint: Total Nasal Symptom Score. Started Aug 1994; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT03882047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882047.